Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Kymera Therapeutics, Inc. has filed 568 SEC EDGAR filings since 22 Jun 2020

SEC filing history

Showing 51-71 of 71 matching filings.

Per page
25
Current page
3
8-K File 001-39460

8-K

Filing date
28 Jun 2021
Reporting date
28 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
17 Jun 2021
Reporting date
16 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
06 May 2021
Reporting date
06 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
16 Mar 2021
Reporting date
12 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
11 Mar 2021
Reporting date
11 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
02 Mar 2021
Reporting date
02 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
12 Jan 2021
Reporting date
12 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
05 Nov 2020
Reporting date
05 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
09 Sep 2020
Reporting date
04 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
01 Sep 2020
Reporting date
27 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39460

8-K

Filing date
25 Aug 2020
Reporting date
20 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .